Gremese, Elisa <br/><br/>
Body weight, gender and response to TNF-α blockers in axial spondyloarthritis.  [electronic resource] 

 -  Rheumatology (Oxford, England)  May 2014 
 - 875-81 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1462-0332 
<br/><br/><label>Standard No.: </label>10.1093/rheumatology/ket433  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adalimumab<br/>Adult<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized--therapeutic use<br/>Antirheumatic Agents--therapeutic use<br/>Axis, Cervical Vertebra<br/>Body Mass Index<br/>Body Weight--physiology<br/>Etanercept<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Immunoglobulin G--therapeutic use<br/>Infliximab<br/>Logistic Models<br/>Male<br/>Middle Aged<br/>Obesity--complications<br/>Overweight--complications<br/>Receptors, Tumor Necrosis Factor--therapeutic use<br/>Retrospective Studies<br/>Sex Factors<br/>Spondylarthritis--drug therapy<br/>Treatment Outcome<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors